MIRATI THERAPEUTICS INC (MRTX) Stock Balance Sheet
NASDAQ:MRTX - Nasdaq - US60468T1051 - Common Stock - Currency: USD
| MRQ (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 36.00M | 53.00M | 19.30M | 20.40M | 700.00K | |||
| Cash Equivalents | 222.70M | 182.20M | 393.70M | 865.20M | 45.90M | |||
| Marketable Securities | 717.70M | 848.60M | 1.08B | 504.50M | 368.50M | |||
| Receivables | 18.00M | 3.70M | 2.50M | 2.30M | 1.60M | |||
| Inventories | 20.20M | 3.00M | N/A | N/A | N/A | |||
| Other Current Assets | 21.50M | 18.40M | 14.10M | 11.30M | 7.80M | |||
| Total Current Assets | 1.04B | 1.11B | 1.51B | 1.40B | 424.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 51.10M | 53.70M | 53.50M | 47.70M | 2.40M | |||
| Investments And Advances | 27.80M | 24.50M | 8.20M | 15.60M | N/A | |||
| Intangibles | 14.10M | 14.90M | N/A | N/A | N/A | |||
| Other Non-Current Assets | 600.00K | 600.00K | 19.00M | 9.20M | 5.40M | |||
| Total Non-Current Assets | 93.60M | 93.60M | 80.80M | 72.50M | 7.80M | |||
| TOTAL ASSETS | 1.13B | 1.20B | 1.59B | 1.48B | 432.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 99.40M | 120.60M | 108.50M | 53.40M | 32.40M | |||
| Accounts Payable | 38.00M | 38.90M | 35.20M | 18.10M | 16.40M | |||
| Other Current Liabilities | N/A | N/A | N/A | 0.00 | 100.00K | |||
| Total Current Liabilities | 137.40M | 159.40M | 143.70M | 71.50M | 48.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 45.90M | 46.70M | 48.10M | 43.90M | 1.00M | |||
| Total Non-Current Liabilities | 45.80M | 46.70M | 48.00M | 43.80M | 1.00M | |||
| TOTAL LIABILITIES | 183.20M | 206.10M | 191.70M | 115.30M | 49.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -2.98B | -2.45B | -1.71B | -1.13B | -772.30M | |||
| Additional Paid In Capital | 3.92B | 3.45B | 3.10B | 2.48B | 1.14B | |||
| Common Shares | 100.00K | 100.00K | 100.00K | 100.00K | 0.00 | |||
| Other Shareholders' Equity | -1.60M | -3.70M | 9.10M | 9.80M | 9.90M | |||
| Shares Outstanding | 70.10M | 57.90M | 55.40M | 50.40M | 39.50M | |||
| Tangible Book Value per Share | 13.30 | 16.95 | 25.22 | 27.00 | 9.68 | |||
| Total Shareholders' Equity | 946.50M | 996.50M | 1.40B | 1.36B | 382.30M | |||
| TOTAL LIABILITIES AND EQUITY | 1.13B | 1.20B | 1.59B | 1.48B | 432.20M | |||
| Statistics | ||||||||
| Current Ratio | 7.54 | 6.96 | 10.49 | 19.63 | 8.68 | |||
| Return On Assets (ROA) | -64.25% | -61.61% | -36.62% | -24.25% | -49.34% | |||
| Return On Equity (ROE) | -76.69% | -74.35% | -41.64% | -26.30% | -55.78% | |||
All data in USD , ROIC based on taxRate of 0.21